This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hearing Loss or Cancer
and you are
between 19 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.

Provided treatments

  • Drug: SPI-1005
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01452607. The sponsor of the trial is Sound Pharmaceuticals, Incorporated and it is looking for 32 volunteers for the current phase.
Official trial title:
A Phase 1, Double-blind, Placebo-controled, Randomized Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SPI-1005 (Ebselen)in Healthy Adult Subjects